Ionis Pharmaceuticals Inc. buy marge
Start price
21.06.15
/
50%
€54.86
Target price
24.05.16
€70.00
Performance (%)
-45.15%
End price
24.05.16
€30.09
Summary
This prediction ended on 24.05.16 with a price of €30.09. Massive losses of -45.15% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -4.576% | -4.576% | 115.323% | 102.506% |
| iShares Core DAX® | -2,53 % | -5,19 % | 4,91 % | 52,00 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % | 21,79 % | 95,66 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % | 31,13 % | 52,99 % |
| iShares S&P 500 | -0,80 % | 0,16 % | 15,78 % | 66,53 % |
Comments by marge for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Isis Pharmaceuticals
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)